2017 Form 10-K Financial Statement
#000143774918005587 Filed on March 27, 2018
Income Statement
| Concept | 2017 | 2016 Q4 | 2016 |
|---|---|---|---|
| Revenue | $24.10M | $5.870M | $23.75M |
| YoY Change | 1.48% | 7.9% | 11.01% |
| Cost Of Revenue | $9.067M | $2.190M | $8.230M |
| YoY Change | 10.16% | 22.35% | 26.73% |
| Gross Profit | $15.04M | $3.680M | $15.52M |
| YoY Change | -3.13% | 0.82% | 4.16% |
| Gross Profit Margin | 62.39% | 62.69% | 65.35% |
| Selling, General & Admin | $11.73M | $2.670M | $8.344M |
| YoY Change | 40.56% | -18.84% | -7.28% |
| % of Gross Profit | 77.99% | 72.55% | 53.75% |
| Research & Development | $4.414M | $1.070M | $4.024M |
| YoY Change | 9.7% | 2.88% | -13.08% |
| % of Gross Profit | 29.35% | 29.08% | 25.92% |
| Depreciation & Amortization | $707.1K | $240.0K | $761.3K |
| YoY Change | -7.12% | -11.11% | -43.13% |
| % of Gross Profit | 4.7% | 6.52% | 4.9% |
| Operating Expenses | $16.14M | $3.740M | $18.17M |
| YoY Change | -11.18% | -13.43% | -13.41% |
| Operating Profit | -$1.105M | -$60.00K | -$2.652M |
| YoY Change | -58.34% | -91.04% | -56.43% |
| Interest Expense | -$1.214M | -$540.0K | -$1.200M |
| YoY Change | 1.21% | 800.0% | 572.95% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$1.320M | -$1.200M | |
| YoY Change | 9.98% | 572.94% | |
| Pretax Income | -$2.424M | -$2.800M | -$3.852M |
| YoY Change | -37.05% | 283.56% | -38.51% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$2.424M | -$2.800M | -$3.852M |
| YoY Change | -37.05% | 283.56% | -38.51% |
| Net Earnings / Revenue | -10.06% | -47.7% | -16.21% |
| Basic Earnings Per Share | -$0.04 | -$0.06 | |
| Diluted Earnings Per Share | -$0.04 | -$40.64K | -$0.06 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 65.41M | 65.13M | |
| Diluted Shares Outstanding | 65.41M | 65.13M |
Balance Sheet
| Concept | 2017 | 2016 Q4 | 2016 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $166.9K | $1.680M | $1.680M |
| YoY Change | -90.07% | 84.62% | 85.02% |
| Cash & Equivalents | $1.680M | ||
| Short-Term Investments | |||
| Other Short-Term Assets | $598.3K | $450.0K | $448.2K |
| YoY Change | 33.5% | 87.5% | 86.81% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $2.693M | $2.230M | $2.230M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $3.458M | $4.358M | $4.358M |
| YoY Change | -20.65% | 46.19% | 46.19% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $69.41K | $149.1K | $2.933M |
| YoY Change | -97.63% | -92.38% | 49.89% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | $2.784M | ||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $123.1K | $102.6K | $102.6K |
| YoY Change | 20.04% | -17.86% | -36.47% |
| Total Long-Term Assets | $4.118M | $3.036M | $3.036M |
| YoY Change | 35.65% | 45.82% | 43.31% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $3.458M | $4.358M | $4.358M |
| Total Long-Term Assets | $4.118M | $3.036M | $3.036M |
| Total Assets | $7.576M | $7.394M | $7.394M |
| YoY Change | 2.47% | 46.04% | 44.99% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $2.479M | $2.640M | $2.639M |
| YoY Change | -6.06% | 17.86% | |
| Accrued Expenses | |||
| YoY Change | |||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $1.224M | $510.0K | $506.9K |
| YoY Change | 141.52% | ||
| Long-Term Debt Due | $3.056M | $2.040M | $2.039M |
| YoY Change | 49.87% | -56.03% | -56.01% |
| Total Short-Term Liabilities | $7.059M | $5.238M | $5.238M |
| YoY Change | 34.76% | -23.48% | -23.89% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $4.671M | $4.590M | $4.588M |
| YoY Change | 1.8% | ||
| Other Long-Term Liabilities | $1.063M | $1.488M | $1.488M |
| YoY Change | -28.57% | ||
| Total Long-Term Liabilities | $5.733M | $1.488M | $6.076M |
| YoY Change | -5.63% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $7.059M | $5.238M | $5.238M |
| Total Long-Term Liabilities | $5.733M | $1.488M | $6.076M |
| Total Liabilities | $12.79M | $11.31M | $11.31M |
| YoY Change | 13.07% | 65.27% | 64.4% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$29.12M | ||
| YoY Change | 15.24% | ||
| Common Stock | $63.41K | ||
| YoY Change | -2.54% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$5.217M | -$3.920M | -$3.920M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $7.576M | $7.394M | $7.394M |
| YoY Change | 2.47% | 46.04% | 44.99% |
Cashflow Statement
| Concept | 2017 | 2016 Q4 | 2016 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$2.424M | -$2.800M | -$3.852M |
| YoY Change | -37.05% | 283.56% | -38.51% |
| Depreciation, Depletion And Amortization | $707.1K | $240.0K | $761.3K |
| YoY Change | -7.12% | -11.11% | -43.13% |
| Cash From Operating Activities | -$1.470M | $490.0K | $320.9K |
| YoY Change | -558.13% | 8.89% | -115.37% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $63.43K | $0.00 | $20.21K |
| YoY Change | 213.91% | -86.72% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$1.713M | -$390.0K | -$1.991M |
| YoY Change | -13.95% | -18.75% | 39.62% |
| Cash From Investing Activities | -$1.776M | -$390.0K | -$2.011M |
| YoY Change | -11.66% | -18.75% | 27.44% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $125.0K | $0.00 | |
| YoY Change | -100.0% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 1.697M | 980.0K | 2.518M |
| YoY Change | -32.58% | 133.33% | -27.11% |
| NET CHANGE | |||
| Cash From Operating Activities | -1.470M | 490.0K | 320.9K |
| Cash From Investing Activities | -1.776M | -390.0K | -2.011M |
| Cash From Financing Activities | 1.697M | 980.0K | 2.518M |
| Net Change In Cash | -1.513M | 1.080M | 827.7K |
| YoY Change | -282.83% | 176.92% | -490.67% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$1.470M | $490.0K | $320.9K |
| Capital Expenditures | $63.43K | $0.00 | $20.21K |
| Free Cash Flow | -$1.534M | $490.0K | $300.7K |
| YoY Change | -610.0% | 8.89% | -113.43% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2016 | aclz |
Adjustments To Additional Paid In Capital Sharebased Compensation Warrants Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationWarrantsRequisiteServicePeriodRecognition
|
806334 | |
| CY2017 | aclz |
Adjustments To Additional Paid In Capital Sharebased Compensation Warrants Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationWarrantsRequisiteServicePeriodRecognition
|
566860 | |
| CY2016Q4 | aclz |
Common Stock Issued And Outstanding Percentage Decrease
CommonStockIssuedAndOutstandingPercentageDecrease
|
0.03 | |
| CY2017 | aclz |
Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
|
862859 | |
| CY2016 | aclz |
Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
|
1268097 | |
| CY2017 | aclz |
Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
|
104676 | |
| CY2016 | aclz |
Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
|
501620 | |
| CY2017 | aclz |
Other Finance Fees
OtherFinanceFees
|
125000 | |
| CY2016 | aclz |
Other Finance Fees
OtherFinanceFees
|
483583 | |
| CY2017 | aclz |
Repayment Of Line Of Credit Noncash Investing And Financing Activities
RepaymentOfLineOfCreditNoncashInvestingAndFinancingActivities
|
||
| CY2016 | aclz |
Repayment Of Line Of Credit Noncash Investing And Financing Activities
RepaymentOfLineOfCreditNoncashInvestingAndFinancingActivities
|
4572223 | |
| CY2017 | aclz |
Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
|
25000 | |
| CY2016 | aclz |
Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
|
25000 | |
| CY2017 | aclz |
Stock Cancelled
StockCancelled
|
||
| CY2016 | aclz |
Stock Cancelled
StockCancelled
|
1900 | |
| CY2017 | aclz |
Stock Issued During Period Shares Stock Options Exercised Noncash
StockIssuedDuringPeriodSharesStockOptionsExercisedNoncash
|
1707692 | |
| CY2017 | aclz |
Stock Issued During Period Shares Warrants Exercised Noncash
StockIssuedDuringPeriodSharesWarrantsExercisedNoncash
|
160096 | |
| CY2016 | aclz |
Stock Issued During Period Value Stock Options And Warrants Exercised Noncash
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercisedNoncash
|
||
| CY2017 | aclz |
Stock Issued During Period Value Stock Options And Warrants Exercised Noncash
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercisedNoncash
|
||
| CY2017Q4 | aclz |
Working Capital Deficit
WorkingCapitalDeficit
|
-3601164 | |
| CY2017Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2479083 | |
| CY2016Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2639008 | |
| CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2692636 | |
| CY2016Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2229610 | |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
775152 | |
| CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
645115 | |
| CY2017Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-41540 | |
| CY2016Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-77329 | |
| CY2017Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
26301748 | |
| CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
3457862 | |
| CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4357924 | |
| CY2017 | us-gaap |
Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
|
572246 | |
| CY2016 | us-gaap |
Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
|
761833 | |
| CY2017Q4 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
3926000 | |
| CY2016Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
25211737 | |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
461764 | |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
295999 | |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
501620 | |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
104676 | |
| CY2017 | us-gaap |
Advertising Cost Policy Expensed Advertising Cost
AdvertisingCostPolicyExpensedAdvertisingCost
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"><div style="display: inline; text-decoration: underline;">Advertising</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company expenses advertising costs as incurred.<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">201<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">7</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">201<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">6</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Advertising expense</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">604,300</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">552,924</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div></div></div> | |
| CY2017 | us-gaap |
Advertising Expense
AdvertisingExpense
|
604300 | |
| CY2016 | us-gaap |
Advertising Expense
AdvertisingExpense
|
552924 | |
| CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
471144 | |
| CY2016Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
349535 | |
| CY2017 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
18966 | |
| CY2016 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
||
| CY2017 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
249125 | |
| CY2016 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
239707 | |
| CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
17273444 | |
| CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
18432724 | |
| CY2017Q4 | us-gaap |
Assets
Assets
|
7575914 | |
| CY2016Q4 | us-gaap |
Assets
Assets
|
7393624 | |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1680127 | |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
908095 | |
| CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
166883 | |
| CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1513244 | |
| CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
772032 | |
| CY2017Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | |
| CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
65939709 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
63415254 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
65939709 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
63415254 | |
| CY2017Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | |
| CY2017 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
| CY2016 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.06 | |
| CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
65938 | |
| CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
63414 | |
| CY2017 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2388699 | |
| CY2016 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3907233 | |
| CY2017 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risks</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The Company is subject to concentrations of credit risk primarily from cash, cash equivalents and accounts receivable.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The Company<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">’s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$250,000.</div> During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company has reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of financial institutions in which it holds deposits.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"> <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The Company's accounts receivable are due from customers, generally located in the United States, Europe, Asia, and Canada. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div> of the Company<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">’s customers accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of its accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require any collateral from its customers.</div></div></div></div> | |
| CY2017Q4 | us-gaap |
Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
|
1135000 | |
| CY2017Q4 | us-gaap |
Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
|
497472 | |
| CY2017 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
9066896 | |
| CY2016 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
8230420 | |
| CY2017Q4 | us-gaap |
Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
|
245584 | |
| CY2016Q4 | us-gaap |
Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
|
429769 | |
| CY2017Q4 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
0 | |
| CY2016Q4 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
43133 | |
| CY2017Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
82868 | |
| CY2016Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
0 | |
| CY2017Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
299937 | |
| CY2016Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
53450 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
7321567 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
9276271 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
||
| CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
||
| CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
4377202 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
6017984 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1058115 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
1080361 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1886250 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2177926 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
7321567 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
9276271 | |
| CY2017 | us-gaap |
Depreciation
Depreciation
|
130037 | |
| CY2016 | us-gaap |
Depreciation
Depreciation
|
273302 | |
| CY2017 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
707081 | |
| CY2016 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
761276 | |
| CY2017 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
| CY2016 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.06 | |
| CY2017 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
35789 | |
| CY2016 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-55649 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.061 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
1 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.4 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-1.207 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.003 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.001 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0 | |
| CY2017Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
47681 | |
| CY2017 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y270D | |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2512203 | |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1939957 | |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
6437726 | |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
4723968 | |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
3925523 | |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2784011 | |
| CY2017 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-10027 | |
| CY2016 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
290 | |
| CY2016 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-2200000 | |
| CY2017 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
||
| CY2017 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-106034 | |
| CY2016 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
||
| CY2017 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7349754 | |
| CY2016 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8343849 | |
| CY2017 | us-gaap |
Gross Profit
GrossProfit
|
15037728 | |
| CY2016 | us-gaap |
Gross Profit
GrossProfit
|
15523026 | |
| CY2017 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | |
| CY2016 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | |
| CY2017 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-612543 | |
| CY2016 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-455242 | |
| CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
346515 | |
| CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
350991 | |
| CY2017 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
246487 | |
| CY2016 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
43014 | |
| CY2017 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
20548 | |
| CY2016 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-22024 | |
| CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
150156 | |
| CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
158266 | |
| CY2017 | us-gaap |
Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
|
||
| CY2016 | us-gaap |
Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
|
50000 | |
| CY2017Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3925523 | |
| CY2016Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
2784011 | |
| CY2017 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
1214476 | |
| CY2016 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
1220840 | |
| CY2017 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
851544 | |
| CY2016 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
492851 | |
| CY2017 | us-gaap |
Interest Paid Net
InterestPaidNet
|
851544 | |
| CY2016 | us-gaap |
Interest Paid Net
InterestPaidNet
|
492581 | |
| CY2017 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
748 | |
| CY2016 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
20833 | |
| CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
12792452 | |
| CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
11313998 | |
| CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7575914 | |
| CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7393624 | |
| CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7059026 | |
| CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5238271 | |
| CY2014Q3 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
6000000 | |
| CY2014Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
3000000 | |
| CY2017Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
3055812 | |
| CY2016Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
2038946 | |
| CY2017Q4 | us-gaap |
Litigation Reserve
LitigationReserve
|
2700000 | |
| CY2017Q4 | us-gaap |
Long Term Line Of Credit
LongTermLineOfCredit
|
4402988 | |
| CY2016Q4 | us-gaap |
Long Term Line Of Credit
LongTermLineOfCredit
|
4588227 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1697442 | |
| CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2517592 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1776293 | |
| CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2010823 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1470182 | |
| CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
320912 | |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2424488 | |
| CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3851584 | |
| CY2017 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1319762 | |
| CY2016 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1200007 | |
| CY2017 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | |
| CY2016 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | |
| CY2017 | us-gaap |
Operating Expenses
OperatingExpenses
|
16142454 | |
| CY2016 | us-gaap |
Operating Expenses
OperatingExpenses
|
18174603 | |
| CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1104726 | |
| CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2651577 | |
| CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
466000 | |
| CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
650000 | |
| CY2017Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
15200000 | |
| CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
123124 | |
| CY2016Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
102574 | |
| CY2017 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
35789 | |
| CY2016 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-55649 | |
| CY2016 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-55649 | |
| CY2017 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
35789 | |
| CY2017 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
35789 | |
| CY2016 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-55649 | |
| CY2017Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1062500 | |
| CY2016Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1487500 | |
| CY2017Q4 | us-gaap |
Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
|
267938 | |
| CY2016Q4 | us-gaap |
Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
|
||
| CY2017 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
||
| CY2016 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
424920 | |
| CY2017Q4 | us-gaap |
Other Short Term Borrowings
OtherShortTermBorrowings
|
1224194 | |
| CY2016Q4 | us-gaap |
Other Short Term Borrowings
OtherShortTermBorrowings
|
506867 | |
| CY2017 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
||
| CY2016 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
129678 | |
| CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
63429 | |
| CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
20206 | |
| CY2017 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
1713759 | |
| CY2016 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
1997759 | |
| CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
548343 | |
| CY2016Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
398187 | |
| CY2017 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
125000 | |
| CY2016 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
||
| CY2017 | us-gaap |
Proceeds From Issuance Of Subordinated Long Term Debt
ProceedsFromIssuanceOfSubordinatedLongTermDebt
|
175000 | |
| CY2017 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
2703000 | |
| CY2016 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
3003105 | |
| CY2017 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1000000 | |
| CY2016 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
||
| CY2017 | us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
895 | |
| CY2016 | us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
7142 | |
| CY2017 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
175000 | |
| CY2016 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
||
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
844557 | |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
794230 | |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
69405 | |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
149115 | |
| CY2017 | us-gaap |
Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
|
P3Y | |
| CY2017 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-116511 | |
| CY2016 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-45612 | |
| CY2017 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
2055558 | |
| CY2016 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
355835 | |
| CY2017 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
250000 | |
| CY2016 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
||
| CY2017 | us-gaap |
Repayments Of Subordinated Debt
RepaymentsOfSubordinatedDebt
|
250000 | |
| CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4414112 | |
| CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4023879 | |
| CY2017Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
50000 | |
| CY2016Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
50000 | |
| CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-31542684 | |
| CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-29118196 | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P4Y138D | |
| CY2017 | us-gaap |
Revenues
Revenues
|
24104624 | |
| CY2016 | us-gaap |
Revenues
Revenues
|
23753446 | |
| CY2017 | us-gaap |
Stock Issued1
StockIssued1
|
1868 | |
| CY2016 | us-gaap |
Stock Issued1
StockIssued1
|
246 | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y302D | |
| CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y36D | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y153D | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
22500000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.39 | |
| CY2017 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
4378588 | |
| CY2016 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
3606875 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.7 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
8202188 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
2485000 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
2422500 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2070000 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
||
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.19 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
127500 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1760425 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
||
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
13590000 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
13125000 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
8302500 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.48 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.39 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.40 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.31 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.15 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
1 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.57 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.50 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
| CY2017Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
||
| CY2017 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
416667 | |
| CY2016 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
5714 | |
| CY2017 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
2400000 | |
| CY2016 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
50000 | |
| CY2017 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
125000 | |
| CY2016 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
||
| CY2017 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
||
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1782858 | |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3920374 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5216538 | |
| CY2017Q4 | us-gaap |
Subordinated Debt
SubordinatedDebt
|
625000 | |
| CY2017 | us-gaap |
Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
|
||
| CY2016 | us-gaap |
Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
|
273859 | |
| CY2017 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</div></div></div> | |
| CY2017 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
65413094 | |
| CY2016 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
65129153 | |
| CY2017 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
65413094 | |
| CY2016 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
65129153 | |
| CY2017 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
65413094 | |
| CY2016 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
65129153 |
